Manulife (Manufacturers Life Insurance)’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.19M | Sell |
109,969
-14,935
| -12% | -$705K | ﹤0.01% | 1151 |
|
|
2025
Q1 | $4.88M | Sell |
124,904
-17,798
| -12% | -$695K | ﹤0.01% | 1173 |
|
|
2024
Q4 | $7.73M | Buy |
142,702
+24,576
| +21% | +$1.33M | 0.01% | 1010 |
|
|
2024
Q3 | $5.96M | Buy |
118,126
+3,892
| +3% | +$196K | 0.01% | 1135 |
|
|
2024
Q2 | $5.02M | Buy |
114,234
+31,401
| +38% | +$1.38M | ﹤0.01% | 1163 |
|
|
2024
Q1 | $4.16M | Sell |
82,833
-1,088
| -1% | -$54.7K | ﹤0.01% | 1267 |
|
|
2023
Q4 | $5.07M | Buy |
83,921
+10,210
| +14% | +$617K | ﹤0.01% | 1166 |
|
|
2023
Q3 | $4.2M | Buy |
73,711
+10,974
| +17% | +$626K | ﹤0.01% | 1192 |
|
|
2023
Q2 | $3.2M | Buy |
62,737
+14,187
| +29% | +$724K | ﹤0.01% | 1272 |
|
|
2023
Q1 | $1.04M | Buy |
+48,550
| New | +$1.04M | ﹤0.01% | 1618 |
|